Citation

Wang H, Yu N, Chen D, Lee KC, Lye PL, Chang JW, Deng W, Ng MC, Lu T, Khoo ML, Poulsen A, Sangthongpitag K, Wu X, Hu C, Goh KC, Wang X, Fang L, Goh KL, Khng HH, Goh SK, Yeo P, Liu X, Bonday Z, Wood JM, Dymock BW, Kantharaj E, Sun ET.: Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile. J Med Chem, Volume 54 (13), 2011

Authors

Bonday Z, Chang JW, Chen D, Deng W, Dymock BW, Fang L, Goh KC, Goh KL, Goh SK, Hu C, Kantharaj E, Khng HH, Khoo ML, Lee KC, Liu X, Lu T, Lye PL, Ng MC, Poulsen A, Sangthongpitag K, Sun ET., Wang H, Wang X, Wood JM, Wu X, Yeo P, Yu N

Journal

J Med Chem

Year

2011

DOI

10.1021/jm2003552

PubMed

21634430

Machine-readable

REST APIRDF